Literature DB >> 12849486

Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy.

Asla Pitkänen1, Thomas P Sutula.   

Abstract

During the past decade, it has become apparent that neural circuits undergo activity-dependent reorganisation. In pathological disorders with recurring episodes of excessive neural activity, such as temporal-lobe epilepsy, brain circuits can undergo continual remodelling. For clinical practice, seizure-induced remodelling implies that after a diagnosis of epilepsy, recurring seizures can cause continuing neural reorganisation and potentially contribute to progressive severity of the epilepsy and to cognitive and behavioural consequences. The alterations induced by seizures include neuronal death and birth, axonal and dendritic sprouting, gliosis, molecular reorganisation of membrane and extracellular-matrix proteins, and intermediates involved in cellular homoeostasis. These changes are influenced by genetic background and seizure type, thus identification of genetic risk factors should be a priority. Therapeutic modification of seizure-induced molecular and cellular responses offers new opportunities for intervention beyond seizure suppression.

Entities:  

Mesh:

Year:  2002        PMID: 12849486     DOI: 10.1016/s1474-4422(02)00073-x

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  172 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

2.  Acupuncture suppresses kainic acid-induced neuronal death and inflammatory events in mouse hippocampus.

Authors:  Seung-Tae Kim; Ah-Reum Doo; Seung-Nam Kim; Song-Yi Kim; Yoon Young Kim; Jang-Hyun Kim; Hyejung Lee; Chang Shik Yin; Hi-Joon Park
Journal:  J Physiol Sci       Date:  2012-07-08       Impact factor: 2.781

Review 3.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

4.  Functional connectivity homogeneity correlates with duration of temporal lobe epilepsy.

Authors:  Zulfi Haneef; Sharon Chiang; Hsiang J Yeh; Jerome Engel; John M Stern
Journal:  Epilepsy Behav       Date:  2015-04-11       Impact factor: 2.937

5.  The role of the subiculum in epilepsy and epileptogenesis.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

Review 6.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 7.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

8.  P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control.

Authors:  Tobias Engel; Alba Jimenez-Pacheco; Maria Teresa Miras-Portugal; Miguel Diaz-Hernandez; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 9.  Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration.

Authors:  Maxime Lévesque; Massimo Avoli; Christophe Bernard
Journal:  J Neurosci Methods       Date:  2015-03-10       Impact factor: 2.390

10.  A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta.

Authors:  Silvia Balosso; Mattia Maroso; Manuel Sanchez-Alavez; Teresa Ravizza; Angelisa Frasca; Tamas Bartfai; Annamaria Vezzani
Journal:  Brain       Date:  2008-10-24       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.